Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Don’t Let NIH Be Dragged Into Applied Research, Outgoing Director Cautions

This article was originally published in The Pink Sheet Daily

Executive Summary

Zerhouni says the agency needs to stay focused on "the fundamental understanding of biological systems," calls for a better technology transfer system to get discoveries to industry.
Advertisement

Related Content

Deals Of The Week: Academic Drug-Discovery Group’s Work Catching Industry’s Notice
BIO Teams With Zerhouni On Quest For "New Big Ideas" To Speed Development
BIO Teams With Zerhouni On Quest For "New Big Ideas" To Speed Development
Next NIH Director's Agenda Includes More International Outreach
Next NIH Director's Agenda Includes More International Outreach
The Politics of Scientific Research: An Interview With NIH Director Zerhouni
Pfizer Collaboration With University Of California Spawns New Research
Pfizer Collaboration With University Of California Spawns New Research

Topics

Advertisement
UsernamePublicRestriction

Register

PS067077

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel